Identification of the signalling steps involved in this IFN-β-dependent injurious macrophage-epithelial cross-talk provides new potential targets for therapeutic strategies to attenuate lung injury without compromising the anti-viral immune response during severe IV pneumonia. Here, IFNB1 is linked to susceptibility to pneumonia measurement.